NasdaqCM - Delayed Quote • USD
Phio Pharmaceuticals Corp. (PHIO)
At close: April 22 at 4:00 PM EDT
Pre-Market: 7:11 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 27.05k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BITTERMAN ROBERT J Chief Executive Officer | Purchase at price 0.91 per share. | Direct | 2,275 | Feb 26, 2024 |
| BITTERMAN ROBERT J Chief Executive Officer | Purchase at price 2.84 - 2.88 per share. | Direct | 5,720 | Jun 30, 2023 |
| FERRARA ROBERT L Director | Purchase at price 3.10 per share. | Direct | 6,200 | Jun 14, 2023 |
| BITTERMAN ROBERT J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2023 |
| CAUWENBERGH GEERT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| BRADFORD PATRICIA A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| LOCKSHIN CURTIS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| KONTULIS CAITLIN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| FREEMAN JONATHAN E PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| FERRARA ROBERT L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| BITTERMAN ROBERT J Officer and Director | Purchase at price 0.39 per share. | Direct | 780 | Dec 14, 2022 |
| BITTERMAN ROBERT J Officer and Director | Purchase at price 0.39 per share. | Direct | 780 | Dec 7, 2022 |
| BITTERMAN ROBERT J Officer and Director | Purchase at price 0.43 per share. | Direct | 860 | Dec 5, 2022 |
| FERRARA ROBERT L Director | Purchase at price 0.41 per share. | Direct | 2,041 | Dec 2, 2022 |
| BITTERMAN ROBERT J Officer and Director | Purchase at price 0.40 - 0.42 per share. | Direct | 1,136 | Nov 29, 2022 |
| FERRARA ROBERT L Director | Purchase at price 0.41 per share. | Direct | 820 | Nov 23, 2022 |
| BITTERMAN ROBERT J Director | -- | Direct | -- | Sep 30, 2022 |
| BRADFORD PATRICIA A Director | -- | Direct | -- | Aug 9, 2022 |
| CAUWENBERGH GEERT Director | -- | Direct | -- | Feb 15, 2022 |
| BITTERMAN ROBERT J Director | -- | Direct | -- | Feb 15, 2022 |
| LOCKSHIN CURTIS Director | -- | Direct | -- | Feb 15, 2022 |
| KONTULIS CAITLIN Officer | -- | Direct | -- | Feb 15, 2022 |
| DORMAN H PAUL Director | -- | Direct | -- | Feb 15, 2022 |
| DISPERSYN GERRIT Chief Executive Officer | -- | Direct | -- | Feb 15, 2022 |
| FREEMAN JONATHAN E PH.D. Director | -- | Direct | -- | Feb 15, 2022 |
| FERRARA ROBERT L Director | -- | Direct | -- | Feb 15, 2022 |
| DISPERSYN GERRIT Chief Executive Officer | Purchase at price 1.63 per share. | Direct | 9,780 | Aug 16, 2021 |
| DISPERSYN GERRIT Chief Executive Officer | Purchase at price 2.56 per share. | Direct | 5,000 | Mar 4, 2021 |
| DISPERSYN GERRIT Chief Executive Officer | Purchase at price 3.03 per share. | Direct | 7,575 | Mar 3, 2021 |
| FERRARA ROBERT L Director | Purchase at price 3.15 per share. | Direct | 2,148 | Mar 3, 2021 |
| CAUWENBERGH GEERT Director | -- | Direct | -- | Mar 1, 2021 |
| BITTERMAN ROBERT J Director | -- | Direct | -- | Mar 1, 2021 |
| LOCKSHIN CURTIS Director | -- | Direct | -- | Mar 1, 2021 |
| KONTULIS CAITLIN Officer | -- | Direct | -- | Mar 1, 2021 |
| DORMAN H PAUL Director | -- | Direct | -- | Mar 1, 2021 |
| DISPERSYN GERRIT Chief Executive Officer | -- | Direct | -- | Mar 1, 2021 |
| FREEMAN JONATHAN E PH.D. Director | -- | Direct | -- | Mar 1, 2021 |
| FERRARA ROBERT L Director | -- | Direct | -- | Mar 1, 2021 |
| DISPERSYN GERRIT Chief Executive Officer | Purchase at price 2.50 per share. | Direct | 5,000 | Aug 19, 2020 |
| CAUWENBERGH GEERT Director | Stock Award(Grant) at price 0.10 per share. | Direct | 22,500 | Nov 18, 2019 |
| BITTERMAN ROBERT J Director | Stock Award(Grant) at price 0.10 per share. | Direct | 30,000 | Nov 18, 2019 |
| KONTULIS CAITLIN Officer | Stock Award(Grant) at price 0.10 per share. | Direct | 23,750 | Nov 18, 2019 |
| DISPERSYN GERRIT Chief Executive Officer | Stock Award(Grant) at price 0.10 per share. | Direct | 35,000 | Nov 18, 2019 |
| FERRARA ROBERT L Director | Stock Award(Grant) at price 0.10 per share. | Direct | 12,750 | Nov 18, 2019 |
| BARRETT JOHN A Officer | -- | Direct | -- | Apr 22, 2019 |
| DISPERSYN GERRIT Chief Executive Officer | -- | Direct | -- | Mar 1, 2019 |
| CAUWENBERGH GEERT Chief Executive Officer | Stock Award(Grant) at price 0.38 per share. | Direct | 57,887 | Feb 28, 2019 |
| CAUWENBERGH GEERT Chief Executive Officer | Stock Award(Grant) at price 0.36 per share. | Direct | 8,096 | Feb 15, 2019 |
| BITTERMAN ROBERT J Director | -- | Direct | -- | Feb 13, 2019 |
| LOCKSHIN CURTIS Director | -- | Direct | -- | Feb 13, 2019 |
Related Tickers
NKGN NKGen Biotech, Inc.
1.4700
+32.43%
BRTX BioRestorative Therapies, Inc.
1.3800
+0.73%
ADIL Adial Pharmaceuticals, Inc.
1.9000
-1.55%
BNTC Benitec Biopharma Inc.
6.72
-3.86%
GRTX Galera Therapeutics, Inc.
0.1908
+3.70%
ASLN ASLAN Pharmaceuticals Limited
0.4550
-11.13%
MLEC Moolec Science SA
2.4700
+78.99%
CLNN Clene Inc.
0.3330
-4.64%
PXMD PaxMedica, Inc.
0.7523
-1.13%
SNGX Soligenix, Inc.
0.4058
-5.85%